📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lutetium Texaphyrin-Celecoxib Conjugate as a Potential Immuno-Photodynamic Therapy Agent (2024)

First Author: An J

Attributed to: Engineering Precision Medicine for the 21st Century funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jacs.4c05978

Publication URI: http://dx.doi.org/10.1021/jacs.4c05978

Type: Journal Article/Review

Parent Publication: Journal of the American Chemical Society

Issue: 28